Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Generic Manufacturers Face Uphill Climb After Federal Circuit’s ‘Skinny Label’ Decision
Feb 15 2022
•
By
Brenda Sandburg
Appeals court declines to rehear 'skinny label' case on generic label carve-outs • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Biosimilars & Generics